Immuron Ltd ADR

Immuron Ltd ADR EBIT Margin

The EBIT Margin (Operating Margin) of Immuron Ltd ADR (IMRN) as of Nov 3, 2026 is -61.39 %. In the previous year, EBIT Margin (Operating Margin) was -73.34 % — a change of -16.30% (higher).

EBIT Margin

-61.39 %

YoY

-16.30%

Last updated:

EBIT Margin (Operating Margin) of Immuron Ltd ADR is 2026 -61.39 % . EBIT Margin (Operating Margin) of Immuron Ltd ADR was 2025 -73.34 % . It decreases by -16.30% higher compared to the previous year.

For Immuron Ltd ADR, the operating (EBIT) margin of -61.4% is up versus -375.0% a few years ago.

The Immuron Ltd ADR EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
-195.04 USD
Jan 1, 2020
-115.82 USD
Jan 1, 2021
-5,748.48 USD
Jan 1, 2022
-375.05 USD
Jan 1, 2023
-197.75 USD
Jan 1, 2024
-118.32 USD
Jan 1, 2025
-73.34 USD
Jan 1, 2026
-61.39 USD
The Immuron Ltd ADR EBIT Margin history
YEAREBIT MarginYoY
-61.39 %-16.30%
-73.34 %-38.01%
-118.32 %-40.17%
-197.75 %-47.27%
-375.05 %-93.48%
-5,748.48 %+4,863.45%
-115.82 %-40.62%
-195.04 %+10.71%
-176.17 %-70.68%
-600.86 %-27.20%
-825.34 %+93.34%
-426.90 %0.00%
-426.90 %+1,872.40%
-21.64 %+194.23%
-7.36 %-45.53%
-13.50 %+175.45%
-4.90 %-13.50%
-5.67 %-58.42%
-13.63 %+1,158.73%
-1.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Immuron Ltd ADR Stock analysis

What does Immuron Ltd ADR do? Immuron Ltd ADR is a biopharmaceutical company listed on the US market in 2017, operating from Carlton. The firm engages in the research, development, and commercialization of polyclonal antibodies across Australia, the United States, and Canada. It operates through Research and Development and Hyper-immune Products segments. Immuron offers Travelan, an over-the-counter medicine and dietary supplement for digestive health, and Protectyn, an immune supplement. The company also develops clinical-stage candidates, including Travelan (IMM-124E) and IMM-529 for gastrointestinal conditions, alongside the pre-clinical IMM-986. Additionally, Immuron provides a technology platform and maintains collaborations for therapeutic development. Immuron Ltd ADR is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Immuron Ltd ADR stock

EBIT Margin (Operating Margin) of Immuron Ltd ADR is -61.39 % in 2026.

EBIT Margin (Operating Margin) of Immuron Ltd ADR changed from -73.34 % to -61.39 %, representing a -16.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Immuron Ltd ADR since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Immuron Ltd ADR with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Immuron Ltd ADR

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Immuron Ltd ADR